SCHEMBL18009207

SCHEMBL18009207

CCOCCN(CCOCC)C(=O)[C@@H]1C[C@@H](OC(=O)/C=C/C(=O)OC)CN1C(=O)OCc1oc(=O)oc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009203 0.93 KCNH2 (0.30) —
SCHEMBL18007447 0.90 — —
SCHEMBL18007445 0.87 — —
SCHEMBL18009389 0.84 CHRM1 (0.31) —
SCHEMBL18007450 0.83 — —
SCHEMBL18007456 0.80 ATM (0.31) —
SCHEMBL18009206 0.79 HRH3 (0.31) —
SCHEMBL18009205 0.78 — —
SCHEMBL18009305 0.77 — —
SCHEMBL18007455 0.75 NAMPT (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback